%D8%B4%D9%8A%D8%AE%D9%88%D8%AE%D8%A9_%D9%85%D8%A8%D9%83%D8%B1%D8%A9Progeriya%D0%9F%D1%80%D0%B0%D0%B3%D0%B5%D1%80%D1%8B%D1%8F%D0%9F%D1%80%D0%BE%D0%B3%D0%B5%D1%80%D0%B8%D1%8F%E0%A6%AA%E0%A7%8D%E0%A6%B0%E0%A7%8B%E0%A6%9C%E0%A7%87%E0%A6%B0%E0%A6%BF%E0%A6%AF%E0%A6%BC%E0%A6%BE%E0%BD%A2%E0%BE%92%E0%BD%A6%E0%BC%8B%E0%BD%A6%E0%BE%94%E0%BC%8B%E0%BD%96%E0%BD%A0%E0%BD%B2%E0%BC%8B%E0%BD%93%E0%BD%91%E0%BC%8BProg%C3%A8riaCategory:ProgeriaProgerieProgeriaProgerieProgeriaProgeriaProgeeriaProgeria%D9%BE%DB%8C%D8%B1%DB%8C_%D8%B2%D9%88%D8%AF%D8%B1%D8%B3ProgeriaProg%C3%A9riaProxeria%D7%A4%D7%A8%D7%95%D7%92%D7%A8%D7%99%D7%94%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%9C%E0%A5%87%E0%A4%B0%E0%A4%BF%E0%A4%AF%E0%A4%BEProg%C3%A9ria%D5%84%D5%A1%D5%B6%D5%AF%D5%A1%D5%AF%D5%A1%D5%B6_%D5%BA%D6%80%D5%B8%D5%A3%D5%A5%D6%80%D5%AB%D5%A1ProgeriaProgeria%E3%83%8F%E3%83%83%E3%83%81%E3%83%B3%E3%82%BD%E3%83%B3%E3%83%BB%E3%82%AE%E3%83%AB%E3%83%95%E3%82%A9%E3%83%BC%E3%83%89%E3%83%BB%E3%83%97%E3%83%AD%E3%82%B8%E3%82%A7%E3%83%AA%E3%82%A2%E7%97%87%E5%80%99%E7%BE%A4Progeria%D0%9F%D1%80%D0%BE%D0%B3%D0%B5%D1%80%D0%B8%D1%8F%ED%94%84%EB%A1%9C%EC%A0%9C%EB%A6%AC%EC%95%84ProgeriaProgerijaProg%C4%93rija%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%9C%E0%A5%87%E0%A4%B0%E0%A4%BF%E0%A4%AF%E0%A4%BEProgeriaProgeriaProgeriaProg%C3%A9riaProgeria%D0%9F%D1%80%D0%BE%D0%B3%D0%B5%D1%80%D0%B8%D1%8FProgeria
about
Sam BernsSammy BassoLeon BothaThe effect of progerin on the involved genes in Hutchinson-Gilford Progeria SyndromeLamin A-processing pathwayPhase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for ProgeriaLonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid LaminopathyClinical Studies of ProgeriaUmbilical Cord Blood Transfusion in Progeria SyndromeA Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With ProgeriaTreatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic AcidPhase I/II Trial of Everolimus in Combination With Lonafarnib in ProgeriaStudy of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
P1050
P2293
AG00781AG00990AG00991AG01710AG03198AG03199AG03259AG03344AG03506AG03513AG06297AG06917AG07493AG08466AG08467AG08671AG10578AG10579AG10587AG10677AG10750AG10801AG11498AG11513AG11572AG15693AG15694AG15695GM00917GM00989GM01177GM01178GM01828GM01972HGADFN001HGADFN003HGADFN003 iPS1BHGADFN003 iPS1CHGADFN003 iPS1DHGADFN004
P5166
Life According to SamProgeria: a rare genetic premature ageing disorderModel of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromesHallmarks of progeroid syndromes: lessons from mice and reprogrammed cellsMolecular insights into the premature aging disease progeriaPredicting Risk at the End of the End: Telomere G-tail as a BiomarkerNF-kB in premature agingPotential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disordersRecent advances in animal and human pluripotent stem cell modeling of cardiac laminopathyPotential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseasesGenetic determinants of human health span and life span: progress and new opportunitiesGenomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A.The eleventh reported case of Mulvihill-Smith syndrome in the literature.From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.The emerging role of alternative splicing in senescence and aging.Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging.MicroRNAs in hereditary and sporadic premature aging syndromes and other laminopathies.A De Novo Mutation Associated With Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome in a Family With Werner SyndromeA novel elastin gene frameshift mutation in a Russian family with cutis laxa: a case reportEffect of Kangaroo Position on Electromyographic Activity, Macrocirculation and Microcirculation of Preterm NewbornsComparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight InfantsCLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference TreatmentEnvironmental Stress and Individualized Sensorimotor Care on Autonomic Nervous System Activity in Premature PopulationAntenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"Weaning Preterm Neonates From Nasal Continuous Positive Airway PressureCO2 Inhalation as a New Treatment Modality for Apnea of PrematurityEffects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTSCalcium (ca),Phosphorus( P) and 25-hydroxyvitamin D(25OHD)] in Infants Born ≤ 32 PMA Gestational Weeks (GA)Increased transport of acetyl-CoA into the endoplasmic reticulum causes a progeria-like phenotypePressure-limited Ventilation Versus Volume-targeted Ventilation in Preterm NewbornsLanguage and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early InterventionEpidemiology of Painful Procedures in NeonatesNifedipine Treatment in Preterm LaborComparison of Two Strategies for Surfactant Prophylaxis in Premature InfantsUrine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature ComplexImproving Right Ventricular Function in Young Adults Born PretermHutchinson-Gilford progeria syndromeRare Alleles and Relatively Frequent Alleles Including 'Healthy Lipid' Emerin p.D149H in the ExAC CohortProgerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cellssFRP3 inhibition improves age-related cellular changes in BubR1 progeroid mice
P921
Q15728552-e1d210b2-46e1-93e2-1826-e4dd249310d4Q25402647-50f16ad3-45ef-9fbc-b89f-7e0322e994adQ2700036-b69d08b1-40ec-85b9-6c94-9e23ca288e63Q56854919-0479820C-5CE4-4002-BC94-2E6C78678C2BQ56855178-393934B0-CA67-454D-9238-F250044AB572Q61921501-5AB86F8A-C117-4EFB-AC75-B347702F6902Q63580522-F858F69F-F5D0-43C8-BAA3-4C2142424B06Q63808127-B35E74B6-DA6D-4508-A356-02A131AD90B4Q64189805-14F78234-7C71-4984-9AFE-2BDB3920F87FQ64707573-3754D256-58B1-4DC1-806B-F1462166B906Q64717758-E81CE828-384A-4996-8287-964602431512Q65316398-80E57ECF-0EC0-4CFE-9ED1-1ACA27C4E3CDQ65378298-DEA6127D-64E9-49D0-8D1F-99600C4E96A0
P1050
description
Enfermedad Humana
@es
Erbkrankheit, die das frühe Altern verursacht
@de
genetic disorder that causes early aging
@en
maladie génétique
@fr
malattia
@it
mongol
@mn
sjukdom som gör att kroppen åldras i förtid
@sv
генетическое заболевание
@ru
рядка генетична болест, при ко ...... тареене, в много ранна възраст
@bg
מחלות
@he
name
Progeeria
@et
Progeria
@da
Progeria
@eu
Progeria
@fi
Progeria
@id
Progeria
@jv
Progeria
@la
Progeria
@nl
Progeria
@pl
Progeria
@ro
type
label
Progeeria
@et
Progeria
@da
Progeria
@eu
Progeria
@fi
Progeria
@id
Progeria
@jv
Progeria
@la
Progeria
@nl
Progeria
@pl
Progeria
@ro
altLabel
Erken yaşlanma hastalığı
@tr
Greisenkrankheit
@de
HGPS
@de
HGPS
@en
HGPS
@pl
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
@en
Hutchinson Gilford progeria syndrome
@en
Hutchinson Gilford syndrome
@en
Hutchinson gilford
@pt
Hutchinson-Gilford Progeria Syndrome
@en
prefLabel
Progeeria
@et
Progeria
@da
Progeria
@eu
Progeria
@fi
Progeria
@id
Progeria
@jv
Progeria
@la
Progeria
@nl
Progeria
@pl
Progeria
@ro
P279
P2888
P2892
P31
P486
P646
P1417
science/Hutchinson-Gilford-syndrome
science/progeria